Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziv-aflibercept for Diabetic Macular Edema
NCT02772497Phase 3Completed
- Sponsor
- Marashi Eye Clinic
- Start
- Jan 2016
- Primary completion
- May 2016
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
01
Overview
A Phase 3 trial of aflibercept in diabetic macular edema (DME), sponsored by Marashi Eye Clinic. Started Jan 2016; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02772497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772497.